Supplementary Fig. S1 . Characterization of mtNUCB1. A Circular Dichroism (CD) spectroscopy of (8μM) mtNUCB1 shows a spectrum (Mean Residue Ellipticity, MRE) characteristic of a fully folded protein with signi cant helical secondary structure. B Thermal unfolding of (8μM) mtNUCB1 monitored by recording CD signal at 222 nm at a heating rate of 1 °C / min indicates an apparent Tm of 48.7 °C. C Composite of representative mtNUCB1 monomers and D dimers imaged by AFM. Integrated xy Scale Bar = 20nm; colorimetric scale bar indicates the height of the particles. E Volume analysis of mtNUCB1 was performed with a bin size = 22 and expressed as probability density for volume (nm ). It reveals a predominant peak at 88 nm and a smaller peak at ~44 nm , as indicated by the dashed lines. F Principal component analysis (PCA) performed on the amplitude of the 12 most signi cant frequencies obtained by Fourier transform shows the di erent shape distribution of mtNUCB1 monomers and dimers. Supplementary Fig. S2 . Aggregation kinetics of Aβ42. A Aggregation kinetics of Aβ42 measured by Thio-T assay, at 37 °C in quiescent conditions, over 24 h. Aβ42 was diluted to various monomeric concentrations and incubated together with 10µM Thio-T. Excitation wavelength was 450 nm and emission wavelength was 485 nm. B Representative Electron Microscopy (EM) images of Aβ42 incubated at 37 °C at di erent monomeric concentrations for 24 h. Scale bar = 500 nm. C The half-time of Aβ42 aggregation was calculated with AmyloFit and graphed together with increasing Aβ42 concentrations in a double logarithmic plot. The data (green circles) results in a straight slope (blue line) that gives a scaling exponent = -0.771 indicative of a secondary nucleation dominant mechanism of aggregation. D Representative immunoEM images of Aβ42 incubated at 37 °C for 0, 1 h or 24 h at 10µM monomeric concentration. Samples were incubated with mouse anti-Aβ 6E10 antibody and 12 nm gold-conjugated secondary antibody. Panels are representative images of early aggregates (right, 100 nm scale bar), proto brils (centre, scale bar = 100 nm) and brils (left, scale bar = 500 nm). Arrowheads indicating 12 nm gold particles (Aβ).
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Aβ42 10μM + mtNUCB1 0.5μM Supplementary Fig. S3 . mtNUCB1 e ect on Aβ42 monomeric content. A Dilution dependent e ect of mtNUCB1 on 2.5µM and B 10µM Aβ42 aggregation, measured by a Thio-T assay, at 37 °C in quiescent conditions, over 40 h and 24 h, respectively. The mtNUCB1 was diluted to various concentrations and incubated together with 2.5µM or 10µM Aβ42 and 10µM Thio-T. Peak radius (nm)
Supplementary Fig. S4 . Characterization of mtNUCB1-Aβ42 proto brils. mtNUCB1-Aβ42 proto brils were puri ed with SEC and characterized by di erent assays. A Direct ELISA shows that both Aβ42 and mtNUCB1 are detected in the sample by using anti-Aβ 6E10 and anti-NUCB1 antibodies. B The mtNUCB1-Aβ42 proto brils were imaged by AFM and the principal component analysis (PCA) was performed on the amplitude of the 12 most signicant frequencies obtained by Fourier transform. The graph shows that the mtNUCB1-Aβ42 complex has a less spread shape distribution compared to mtNUCB1 (monomers + dimers). C DLS analysis shows the hydrodynamic peak radius of mtNUCB1-Aβ42 proto brils (6.16 nm) and mtNUCB1 (5.6 nm). Probability Density Supplementary Fig. S5 . mtNUCB1 binding to di erent amyloidogenic pre-brillar species generates proto brils of di erent sizes. mtNUCB1 was incubated together with A Aβ 42, B hIAPP, C α-synuclein, or D the transthyretin V30M mutant and the obtained proto brils were puri ed by SEC and imaged by AFM. The volumetric analysis performed on the images is displayed as discrete probability density functions. It indicates a size peak of 250 nm , 550 nm , 600 nm and 200 nm for mtNUCB1-Aβ42, mtNUCB1-hIAPP, mtNUCB1-α-synuclein and mtNUCB1-V30M proto brils, respectively, as indicated by the dashed lines. The area under the curve represents the size distribution and is an indication of volume heterogeneity. 
